ela2 (Proteintech)
Structured Review

Ela2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 315 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ela2/product/Proteintech
Average 96 stars, based on 315 article reviews
Images
1) Product Images from "Sustained STING-IRF7 signaling aggravates LPS-induced endometrial inflammation via excessive neutrophil extracellular traps generation"
Article Title: Sustained STING-IRF7 signaling aggravates LPS-induced endometrial inflammation via excessive neutrophil extracellular traps generation
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2025.1671848
Figure Legend Snippet: STING deficiency suppressed NETs formation in endometritis. (A) Representative images of ELA2 (red) in LPS-treatment Tmem173 gt mice endometrial tissues or control for 24 h at 400 × magnification (scale bar = 25 μm). The DNA was staining with DAPI. (B) Quantification of ELA2-positive cells in the endometrial tissues (n=10). One-way ANOVA test was applied with *** P <0.001 (WT vs. Tmem173 gt in LPS group). (C) Representative images of citH3 (green) in LPS-treatment Tmem173 gt mice endometrial tissues or control for 24 h at 400 × magnification (scale bar = 25 μm). The DNA was staining with DAPI. (D) Quantification of citH3 positive cells in the endometrial tissues (n=10). One-way ANOVA test was applied with ** P <0.01 (WT vs. Tmem173 gt in LPS group). (E) Representative immunohistochemical staining of ELA2 in endometrial tissues of chronic endometritis or control at 400 × magnification (scale bar = 25 μm). (F) The area of ELA2 were quantified (n=8). One-way ANOVA test was applied with ** P <0.01 (WT vs. Tmem173 gt in LPS group). (G) Representative immunohistochemical staining of MPO in endometrial tissues of chronic endometritis or control at 400 × magnification (scale bar = 25 μm). (H) The area of MPO were quantified (n=8). One-way ANOVA test was applied with ** P <0.01 (WT vs. Tmem173 gt in LPS group). (I) Representative immunoblots of citH3, ELA2 and MPO in LPS-treatment Tmem173 gt mice endometrial tissues or control endometrium tissues. (J) MPO concentration in endometrial tissues of LPS-treatment Tmem173 gt mice endometrial tissues or control (n=6). One-way ANOVA test was applied with * P <0.05 (WT vs. Tmem173 gt in PBS group), * P <0.05 (WT vs. Tmem173 gt in LPS group). (K) Detection of NETs formed by flow cytometry in mice bone marrow neutrophils stimulated with STING agonis cGAMP and or STING inhibitor H-151. (L) Quantification of citH3 + cells on neutrophils stimulated with STING agonis cGAMP and or STING inhibitor H-151 by flow cytometry. Representative flow data showing citH3 + cells defined as NETs. One-way ANOVA test was applied with ** P <0.001, * P <0.05.
Techniques Used: Control, Staining, Immunohistochemical staining, Western Blot, Concentration Assay, Flow Cytometry
Figure Legend Snippet: Neutrophil NETs formation in chronic endometritis patients. (A) Representative immunohistochemical staining of STING, IRF7, LCN2 and MC4R in endometrial tissues of chronic endometritis or control at 400 × magnification (scale bar = 100 μm). (B) Representative immunohistochemical staining of ELA2 in endometrial tissues of chronic endometritis or control at 400 × magnification (scale bar = 25 μm). (C) The area of ELA2 was quantified (n=6). Student’s t test was applied with ** P <0.01. (D) Representative immunofluorescence image of citH3 in endometrial tissues of chronic endometritis or control at 400 × magnification (scale bar = 25 μm). The staining color of citH3 was green. The DNA was staining with DAPI. (E) The mean of citH3 were quantified (n=6). Student’s t test was applied with * P <0.05. (F) Representative immunofluorescence image of MPO in endometrial tissues of chronic endometritis or control at 400 × magnification (scale bar = 25 μm). The staining color of MPO was red. The DNA was staining with DAPI. (G) The mean of MPO were quantified (n=6). Student’s t test was applied with *** P <0.001.
Techniques Used: Immunohistochemical staining, Staining, Control, Immunofluorescence
